Danaher's net earnings increase 13% to $680.6 million in third quarter 2014

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2014.

Net earnings for the third quarter ended September 26, 2014 were $680.6 million, or $0.95 per share on a diluted basis, a 13% increase over diluted net earnings per share of $0.84 for the third quarter of 2013. Included in third quarter 2014 diluted net earnings per share is a $0.04 per share after-tax gain on the divestiture of a product line and a $0.01 per share benefit from discrete tax items.

Revenues for the third quarter of 2014 were $4.9 billion, 4.5% higher than the $4.7 billion reported for the third quarter of 2013. Core revenues increased 3% in the third quarter of 2014 compared to the third quarter of 2013.

The Company anticipates that GAAP diluted net earnings per share for the quarter ending December 31, 2014 will be in the range of $1.00 to $1.04. Included in this range is approximately $125 million, or approximately $0.13 per diluted share, of anticipated productivity charges that are partially offset by an approximate $0.07 per diluted share anticipated gain on the sale of marketable securities.

Thomas P Joyce, Jr., President and Chief Executive Officer, stated, "The Danaher team executed well, using the Danaher Business System to expand margins, generate strong cash flow performance, drive meaningful share gains and deliver better-than-expected earnings. As we plan for 2015, we remain mindful of the challenging macroeconomic outlook including the recently stronger dollar. However, we believe our focus on high-impact growth investments and margin expansion, combined with our robust balance sheet and M&A capacity, position us to finish 2014 well and drive long term results."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2019, June 19). Danaher's net earnings increase 13% to $680.6 million in third quarter 2014. News-Medical. Retrieved on December 26, 2024 from https://www.news-medical.net/news/20141016/Danahers-net-earnings-increase-1325-to-246806-million-in-third-quarter-2014.aspx.

  • MLA

    Danaher. "Danaher's net earnings increase 13% to $680.6 million in third quarter 2014". News-Medical. 26 December 2024. <https://www.news-medical.net/news/20141016/Danahers-net-earnings-increase-1325-to-246806-million-in-third-quarter-2014.aspx>.

  • Chicago

    Danaher. "Danaher's net earnings increase 13% to $680.6 million in third quarter 2014". News-Medical. https://www.news-medical.net/news/20141016/Danahers-net-earnings-increase-1325-to-246806-million-in-third-quarter-2014.aspx. (accessed December 26, 2024).

  • Harvard

    Danaher. 2019. Danaher's net earnings increase 13% to $680.6 million in third quarter 2014. News-Medical, viewed 26 December 2024, https://www.news-medical.net/news/20141016/Danahers-net-earnings-increase-1325-to-246806-million-in-third-quarter-2014.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Danaher signs definitive transaction agreement with Nobel Biocare